April 07, 2025 03:41 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bengal BJP leaders participate in Ram Navami rallies across state | PM Modi to inaugurate new Pamban Rail Bridge, connecting Rameswaram to Indian mainland, today | Huge protests erupt in Kolkata, Chennai after parliament passes Waqf Amendment Bill | India’s growth outlook dims after US tariffs; deeper rate cuts likely, say analysts: Report | K Annamalai says he is not in a race to become Tamil Nadu BJP's next president | PM Modi meets Muhammad Yunus in Bangkok amid bilateral tension in first since Hasina's fall | Calcutta HC blasts TMC leader-headed film federation over infringement of directors' fundamental rights | BJP demands Mamata Banerjee's resignation over Supreme Court verdict quashing Bengal govt jobs | Rajya Sabha passes Waqf (Amendment) Bill 2025 after marathon debate, 128 voted in favour | West Bengal: Mamata Banerjee accuses BJP, CPI (M) for SC verdict on SSC recruitment, vows to support affected teachers
WHO discontinues trials of hydroxychloroquine, lopinavir/ritonavir in COVID-19 treatment

WHO discontinues trials of hydroxychloroquine, lopinavir/ritonavir in COVID-19 treatment

Jul 05, 2020, at 08:35 am

Geneva/IBNS: The World Health Organisation (WHO) has informed that it is discontinuing the use of hydroxychloroquine and lopinavir/ritonavir arms in COVID-19 treatment for hospitalised patients as a part of its Solidarity Trial, stating the drugs had little effect on reducing the mortality rate.

Close menu